Patients with mesothelioma treated with cisplatin and raliterciride may remain longer than those treated with cisplatin alone, according to a recent study in Europe and Canada (J Clin Oncol 2005, October 1; 23 (28): 6881- 9). Raltitrexed (Tomudex) affects the ability of tumor cells to proliferate and to produce ribonucleic acid from dioxin or DNA. • Read More »